HemaSphere
(Aug 2023)
S184: SAFETY AND OUTCOMES FOLLOWING IMMUNOSUPPRESSIVE THERAPY WITH ATG/CYCLOSPORIN +/- ELTROMBOPAG FOR OLDER PATIENTS WITH SEVERE APLASTIC ANEMIA
- Ashvind Prabahran,
- Jibran Durrani,
- Juan Coelho Da Silva,
- Ruba Shalhoub,
- Jennifer Lotter,
- Olga Rios,
- Colin Wu,
- Bhavisha Patel,
- Young Neal,
- Emma Groarke
Affiliations
- Ashvind Prabahran
- 1 National Heart Lung & Blood Institute, Hematology Branch, Bethesda, United States
- Jibran Durrani
- 1 National Heart Lung & Blood Institute, Hematology Branch, Bethesda, United States
- Juan Coelho Da Silva
- 1 National Heart Lung & Blood Institute, Hematology Branch, Bethesda, United States
- Ruba Shalhoub
- 5 National Heart Lung & Blood Institute, Office of Biostatistics Research, Bethesda, United States
- Jennifer Lotter
- 1 National Heart Lung & Blood Institute, Hematology Branch, Bethesda, United States
- Olga Rios
- 1 National Heart Lung & Blood Institute, Hematology Branch, Bethesda, United States
- Colin Wu
- 5 National Heart Lung & Blood Institute, Office of Biostatistics Research, Bethesda, United States
- Bhavisha Patel
- 1 National Heart Lung & Blood Institute, Hematology Branch, Bethesda, United States
- Young Neal
- 1 National Heart Lung & Blood Institute, Hematology Branch, Bethesda, United States
- Emma Groarke
- 1 National Heart Lung & Blood Institute, Hematology Branch, Bethesda, United States
- DOI
-
https://doi.org/10.1097/01.HS9.0000967648.89045.93
- Journal volume & issue
-
Vol. 7
p.
e8904593
WeChat QR code